Mahkam Zanganeh, Co-CEO & President at Summit Therapeutics Inc. (SMMT), bought 40,305,459 shares at $1.05 ($42.3M) on 2023-03-08, disclosed to the SEC on 2023-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.05 | 6,748,629 | $7.1M | 16.7% |
| 2 | $1.05 | 16,778,415 | $17.6M | 41.6% |
| 3 | $1.05 | 16,778,415 | $17.6M | 41.6% |
| Total | $1.05 avg | 40,305,459 | $42.3M | 100% |
| Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| SMMT | BUY | 2025-09-11 | $11.9M | — | Filing → |
| SMMT | BUY | 2024-03-27 | $539K | — | Filing → |